Sequenom's HerediT Universal

Sequenom Laboratories, a wholly owned subsidiary of Sequenom, has launched the HerediT Universal carrier screening test, expanding the firm's reach into the universal carrier screening market. The HerediT Universal screens for more than 250 genetic diseases by analyzing over 2,000 genetic mutations and can be performed preconception or at any time during pregnancy, the firm said. The test is being offered in collaboration with Recombine, a clinical genetic testing firm.